Search | Pikumil

Sarthak Jain added blog Health
2026-08-14 07:14:24 -

US Keytruda Market Growth and Future Outlook
The United States oncology landscape is witnessing a significant transformation with the continued success of immunotherapy, particularly with the US Keytruda Market emerging as a dominant force in cancer treatment. Keytruda (pembrolizumab), a PD-1 inhibitor developed by Merck & Co., has revolutionized the management of various malignancies, offering new hope for patients with...

0 Comments 0 Shares 123 Views 0 Reviews

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-06-23 11:05:10 -

Keytruda Market Strategic Insights and Future Trends
The global Keytruda Market was valued at USD 31.4 billion in 2025 and is projected to grow from USD 32.7 billion in 2026 to USD 25.0 billion by 2033, registering a CAGR of -3.8% from 2026 to 2033. While Keytruda (pembrolizumab) remains one of the most successful immunotherapy drugs globally, the market is expected to face headwinds over the forecast period due to patent expiration,...

0 Comments 0 Shares 685 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Khabale added blog Other
2026-08-04 01:19:18 -

Keytruda Market Size, Share, Demand, Industry Trends, Clinical Pipeline, Competitive Landscape, and Forecast Through 2033
Navigating the Global Keytruda Market: Strategic Growth, Patent Landscapes, and Future Oncology Frontiers The global oncology therapeutics market continues to experience a structural transformation, transitioning away from traditional, highly toxic chemotherapy regimens toward precision immunotherapy. At the epicentre of this clinical and commercial revolution stands Keytruda...

0 Comments 0 Shares 334 Views 0 Reviews

Please log in to like, share and comment!